Uzbekistan Strengthens Childhood Cancer Care with WHO Support
Uzbekistan is expanding efforts to improve childhood cancer diagnosis and treatment through a partnership with the World Health Organisation (WHO), aiming to increase survival rates and reduce inequalities in access to care.
According to WHO Europe, the country has become a regional leader in implementing the WHO Global Initiative for Childhood Cancer and is participating in the Global Platform for Access to Childhood Cancer Medicines. The programme helps ensure a stable supply of quality-assured cancer medicines and supports improvements in diagnosis, treatment and specialist training.
A WHO technical mission to Uzbekistan this year focused on strengthening diagnostic pathways, expanding access to essential medicines and enhancing training in paediatric oncology and palliative care. The initiative is supported by international partners, including World Health Organization and St. Jude Children’s Research Hospital.
WHO estimates that more than 80% of children with cancer can survive when diagnosed early and given appropriate treatment. However, survival rates remain significantly lower in countries with limited access to specialised care and medicines.
Uzbekistan has adopted a national strategy for childhood cancer care and is working to raise survival rates, improve early detection and ensure wider access to specialised treatment for children across the country.
